Related Experiment Videos
Effects of carvedilol on renal function
1Department of Internal Medicine, University Hospital, Vrije Universiteit, Brussels, Belgium.
Insights
Carvedilol effectively lowers blood pressure in essential hypertension. Both acute and chronic use preserve renal blood flow, reduce vascular resistance, and demonstrate antihypertensive and renal vasodilating properties.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Background:
- Essential hypertension is a prevalent condition requiring effective treatment.
- Understanding the renal effects of antihypertensive drugs is crucial for patient management.
Purpose of the Study:
- To investigate the acute and chronic effects of carvedilol on blood pressure, renal hemodynamics, and renal function in patients with essential hypertension.
Main Methods:
- A randomized, double-blind, placebo-controlled study.
- Involved acute (single dose) and chronic (treatment period) administration of carvedilol.
- Assessed blood pressure, heart rate, renal blood flow, renal vascular resistance, glomerular filtration rate, filtration fraction, plasma renin activity (PRA), and plasma aldosterone.
Main Results:
- Acute carvedilol administration reduced blood pressure without reflex tachycardia, preserved renal blood flow, and decreased renal vascular resistance, though glomerular filtration rate and filtration fraction were reduced.
- Chronic carvedilol treatment significantly lowered blood pressure, heart rate, PRA, and aldosterone, while maintaining renal blood flow, glomerular filtration rate, and filtration fraction, with a significant decrease in renal vascular resistance.
Conclusions:
- Carvedilol exhibits significant antihypertensive effects.
- The drug possesses renal vasodilating properties, beneficial for both acute and chronic essential hypertension management.
Abstract:
A randomized, double-blind, placebo-controlled study was conducted to study the effects of acute and chronic administration of carvedilol in essential hypertension, with special emphasis on renal haemodynamics and function. Acute administration of a single dose of 50 mg carvedilol reduced systolic and diastolic blood pressure without inducing reflex tachycardia. Renal blood flow was preserved; accordingly, renal vascular resistance was significantly reduced. A significant reduction in the glomerular filtration rate and filtration fraction was observed. Plasma renin activity (PRA) and plasma aldosterone values were not changed. Chronic carvedilol treatment produced a significant fall in systolic and diastolic blood pressure, heart rate, PRA and plasma aldosterone. Renal blood flow, glomerular filtration rate and filtration fraction also remained unchanged; renal vascular resistance decreased significantly. It is concluded that carvedilol possesses definite antihypertensive and renal vasodilating properties, both acutely and after chronic treatment.